CPHRF - Notice of Cipher Pharmaceuticals Q4 2019 Conference Call

February, 20 2020 05:00 PM Companhia Siderurgica Paulista Nova Cosipa

Canada NewsWire

OAKVILLE, ON, Feb. 20, 2020

OAKVILLE, ON, Feb. 20, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q4 2020 financial results conference call on Thursday, March 26, 2019.

CONFERENCE CALL DETAILS

DATE:

Thursday, March 26, 2020

TIME:

8:30 a.m. EDT

DIAL IN NUMBER:

(416) 764-8688 or (888) 390-0546

CONFERENCE ID:

02880904

REPLAY:

(888) 390-0541 (playback code 880904 #)

Available until midnight April 2, 2020

WEBCAST:

The audio webcast can be accessed at http://cipher.investorroom.com/ under Investor Relations or at https://event.on24.com/wcc/r/2203231/4C6EB61DB02BC18A6F5927498CF2787D

About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

View original content: http://www.newswire.ca/en/releases/archive/February2020/20/c0808.html

James Bowen, CFA, LodeRock Advisors, 416-519-9442, James.bowen@loderockadvisors.comCopyright CNW Group 2020

Company Name:	Companhia Siderurgica Paulista Nova Cosipa
Stock Symbol:	CPHRF
Market:	OTC
Website:	cipherpharma.com

Twitter